Sepsis DART™ Impact Estimator

See What SEP-1 Performance Means for Your Medicare Reimbursement

Enter your hospital's bed count to see estimated revenue and Medicare exposure under CMS Value-Based Purchasing.

Hospital bed count 450

100 900

Estimated Net Patient Revenue

$270.0M

Modeled estimate: bed count × $600K per staffed bed (national benchmark, see methodology).

Estimated Medicare Revenue

$41.9M

Based on the national average Medicare share of hospital net patient revenue (15.5%).

Reimbursement at Risk (VBP)

$0.84M

Up to 2% of Medicare revenue can be withheld under CMS Value-Based Purchasing.

16%+

Demonstrated SEP-1 bundle compliance improvement within 90 days of Sepsis DART deployment.

Schedule a Demo to Discuss Your Numbers

Methodology: Net patient revenue is modeled at $600,000 per staffed bed annually, a national benchmark derived from American Hospital Association and Kaiser Family Foundation cost-per-bed data. This is the softest figure in this estimate: published hospital revenue varies widely by region, case mix, and hospital size, and actual per-bed revenue can run higher, particularly at larger academic and specialty centers. Medicare revenue is then estimated using the national average Medicare share of hospital net patient revenue, 15.5% in 2023 (Definitive Healthcare analysis of Medicare Cost Report data). Reimbursement at risk reflects the maximum 2% withhold under the CMS Hospital Value-Based Purchasing Program for hospitals falling short of SEP-1 and related quality thresholds. SEP-1 compliance improvement is based on published clinical research (TJU study). This is a national-average model, not a hospital-specific projection. Schedule a demo for an assessment specific to your hospital.